(Allergan plc)

	AGN latest price $217.8568 (-3.34%) ($217.5479 - $221.8139) on Fri. Jun. 24, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.7% (three month average)
RSI	26
Latest Price	$217.8568(-3.34%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.8% a day on average for past five trading days.
Weekly Trend	AGN declines -3.3% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(53%)    XLV(51%)    XBI(47%)    ARKG(44%)    IVE(42%)
Factors Impacting AGN price	AGN will decline at least -1.35% in a week (0% probabilities).   VIXM(-30%)    TLT(-16%)    UUP(-13%)    IPO(-5%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.35% (StdDev 2.7%)
Hourly BBV	0 ()
Intraday Trend	-0.3%

Resistance Level	$231.22
5 Day Moving Average	$222.87(-2.25%)
10 Day Moving Average	$226.85(-3.96%)
20 Day Moving Average	$231.22(-5.78%)
To recent high	-19.2%
To recent low	11.9%
Market Cap	$71.827b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed